IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAMAIONI, Emidio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.347
EU - Europa 2.662
AS - Asia 939
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 6
OC - Oceania 2
Totale 6.971
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.338
UA - Ucraina 661
IE - Irlanda 610
IT - Italia 421
SG - Singapore 323
SE - Svezia 249
HK - Hong Kong 247
DE - Germania 180
FI - Finlandia 160
CN - Cina 124
RU - Federazione Russa 124
VN - Vietnam 120
TR - Turchia 75
GB - Regno Unito 54
FR - Francia 47
PL - Polonia 38
CH - Svizzera 24
BE - Belgio 23
KR - Corea 22
CZ - Repubblica Ceca 17
NL - Olanda 15
GR - Grecia 12
RO - Romania 12
AT - Austria 11
EG - Egitto 7
IL - Israele 7
EU - Europa 6
LB - Libano 6
MX - Messico 5
UZ - Uzbekistan 5
CL - Cile 4
JP - Giappone 4
SV - El Salvador 4
ID - Indonesia 3
BR - Brasile 2
AU - Australia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
IR - Iran 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SA - Arabia Saudita 1
Totale 6.971
Salva come PNG Salva come JPEG
Città #
Dublin 606
Chandler 555
Jacksonville 408
San Mateo 336
Hong Kong 245
Singapore 237
Boardman 214
Santa Clara 172
Altamura 165
Medford 156
Princeton 154
Dong Ket 119
Perugia 107
Lawrence 105
Wilmington 103
Ann Arbor 97
Andover 86
Izmir 74
Redmond 58
Des Moines 55
Saint Petersburg 49
Beijing 48
Ashburn 27
Helsinki 25
Norwalk 23
Seoul 22
Brussels 21
San Paolo di Civitate 21
Los Angeles 20
Woodbridge 18
Dallas 14
Munich 13
Bucharest 11
Den Haag 11
Redwood City 11
Auburn Hills 10
New York 10
Rome 10
Shanghai 9
Falls Church 8
Milan 8
Brno 7
Cairo 7
Chicago 7
Krakow 7
San Diego 7
Lausanne 6
Mcallen 6
Ness Ziona 6
Olomouc 6
Renton 6
Simi Valley 6
Zhengzhou 6
Florence 5
Frankfurt Am Main 5
Kraków 5
Spoleto 5
Bologna 4
Centro 4
Fairfield 4
Gigante 4
Montefalco 4
Moscow 4
Tappahannock 4
Winston-Salem 4
Cassino 3
Collazzone 3
Detroit 3
Fremont 3
Houston 3
Malang 3
Nanjing 3
San Giustino 3
Strasbourg 3
Terni 3
Wuhan 3
Cambridge 2
Città di Castello 2
Coalville 2
Esslingen am Neckar 2
Fuzhou 2
La Canada Flintridge 2
Las Vegas 2
Mestrino 2
Misano Adriatico 2
Nea Smyrni 2
Nuremberg 2
Pittsford 2
Radomsko 2
Shenzhen 2
Tübingen 2
Warsaw 2
Abidjan 1
Amsterdam 1
Auckland 1
Barcelona 1
Bastia umbra 1
Birmingham 1
Boydton 1
Brescia 1
Totale 4.643
Salva come PNG Salva come JPEG
Nome #
Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations 120
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 101
Structure-activity relationships of bisphophonate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists 87
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 82
Towards New Neuroprotective Agents: Design and Synthesis of Thieno[2,3-c]-isoquinolinon-5-one as a Potent PARP-1 Inhibitor. 81
Spiro[2.2]pentane as a Dissymmetric Scaffold for Conformationally Constrained Analogues of Glutamic Acid: Focus on Racemic 1-Aminospiro[2.2]pentyl-1,4-dicarboxylic Acids 79
Spiro[2.2]pentane as a dyssymetric scaffold for conformationally constrained analogues of glutamic acid: diastereodivergent synthesis of 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 77
Novel PARP Inhibitors: Synthesis and Molecular Modeling Studies 76
Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage 76
Design and synthesis of 4H-thieno[2,3-c]isoquinolin-5-one derivatives as potent PARP-1 inhibitors, on route of new antiischemic agents 75
2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors 74
Metabotropic glutamate receptors: structure and new subtype-selective ligands 74
On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. 73
PARP inhibitors: polypharmacology versus selective inhibition 70
Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis 69
Integrated Fragment-Based Approaches on the Route to Novel IDO1 Modulators 69
Binding Mode of 6ECDCA, a Potent Bile Acid Agonist of the Farnesoid X Receptor (FXR) 68
Adenosine receptor agonists: Synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA 67
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 67
Preparation and use of nucleotide bisphosphate as P2Y antagonists 66
Rat Brain Guanosine Binding Site:Biological Studies and Pseudo Receptor Construction 65
1μs Molecular Dynamics Simulations to study the poisoning effect of the PARP-1 full length enzyme 65
Targeting the FXR nuclear receptor through a virtual screening approach 64
N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for "green" ligand-exchange chromatography applications 64
Effects of new arylazido compounds of pyridoxal phosphate on ecto-ATPase activity of guinea pig tissues 62
Adenosine Deaminase: Functional Implications and Different Classes of Inhibitors 61
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles. 61
Dexpramipexole improves bioenergetics and outcome in experimental stroke 61
Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ 60
Design, Molecular Modeling Studies, Synthesis and Preliminary Evaluation of Novel PARP-1 Inhibitors on the Road of Antiischemic Agents 59
Chiral separation of helical chromenes with chloromethyl phenylcarbamate polysaccharide-based stationary phases 59
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. 58
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy. 58
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures 58
BF3·Et2O-Promoted Decomposition of Cyclic α-Diazo-β-Hydroxy Ketones: Novel Insights into Mechanistic Aspects 57
Derived chromatographic indices as effective tools to study the self-aggregation process of bile acids 56
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. 56
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 56
Chromatographic hydrophobicity index: a high-throughput tool to estimate the critical micellar concentration of bile acids 56
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. 56
Modeling of Poly(ADP-ribose)polymerase (PARP) Inhibitors. Docking of Ligands and QSAR 55
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity 55
The Janus-faced nature of IDO1 in infectious diseases: Challenges and therapeutic opportunities 54
The relationship between s. Aureus and branched-chain amino acids content in composite cow milk 54
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide. 53
Adenosine deaminase inhibitors: Structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogues 53
Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO). 52
Bile acids: property-activity relationship and molecular modelling studies 52
8-Bromo-9-etiladenine come tools per l’ottenimento di antagonisti selettivi per il recettore adenosinico A2B 52
Chiral ligand-exchange separation and resolution of extremely rigid glutamate analogues: 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 51
Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites 51
Compendio teorico-pratico di analisi farmaceutica. Riconoscimento delle sostanze solide iscritte nelle vigenti farmacopee 51
Branched-chain amino acids as potential diagnostic and prognostic disease biomarkers 50
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors 50
Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres 50
Highlights at the gate of tryptophan catabolism: a review on the mechanism of activation and regulation of indoleamine 2,3-dioxigenase (IDO), a novel target in cancer disease 49
Chiral ligand-exchange separation and resolution ofextremely rigid glutamate analogs: 1-aminospiro[2.2]pentyl-1,4-dicarboxylicacids. 49
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis 49
Synthesis and Biological Evaluation of 2-(3’-(1H-tetrazol-5-yl)bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 Receptor 48
Fast chromatographic determination of the bile salt critical micellar concentration 47
Molecular determinats for metabotropic glutamate receptor activation and blockade. Molecular dynamics and electrostatic potential analysis studies 47
Hydrophobic Amino Acid Content in Onions as Potential Fingerprints of Geographical Origin: The Case of Rossa da Inverno sel. Rojo Duro 47
Enantioselective HPLC analysis to assist the chemical exploration of chiral imidazolines 47
Estimating the hydrophobicity extent of molecular fragments using reversed‐phase liquid chromatography 46
Stereoselective Synthesis and Preliminary Evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): Identification of (+)-3-MATIDA as a Novel mGluR1 Competitive Antagonist 46
Studies on the interaction between PARP’s catalytic site and inhibitors. Design and synthesis of new class of inhibitor derivatives 46
Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors 46
Insights in the PARP1 poisoning effect 46
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 46
Studies guanosine binding sites in rat brain: S.A.R. analysis and pharmacophore design 45
On the Way to Selective PARP-2 Inhibitors: Design, Synthesis and Preliminary Evaluation of a Series of Isoquinolinone Derivatives 45
Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure Activity Relationship of a Series of Body and Side Chain Modified Analogs of Chenodeoxycholic Acid 45
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. 45
One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and Hydroxylases 45
Dominant Factors Affecting the Chromatographic Behaviour of Bile Acids 44
Pharmacology of the highly selective A1 adenosine receptor agonist2-chloro-N6-cyclopentyladenosine. 44
Inhibitory Effects of 1-Deazaadenosine Analogues on HIV Replication and Adenosine Deaminase 44
Use of RP-HPLC on a Dynamically Coated Artificial Membrane to Predict Intestinal Absorption of Bile Acids 43
Synthesis, molecular modelling and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO) 43
Rat brain guanosine binding site. Biological studies and pseudo-Receptor construction 42
Synthesis, enantiomeric separation and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO), a novel target for cancer therapy 42
Design, Synthesis, Crystallographic Studies and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors. 42
Xaa-prolyl dipeptidyl aminopeptidase may play an important role in biofilm formation by Streptococcus mutans 42
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy 42
The relationships between somatic cells and isoleucine, leucine and tyrosine content in cow milk 42
HYDAMTIQ: A New, Potent PARP-1 Inhibitor with Neuroprotective Properties 41
Synthesis and Receptor Affinity of Polysubstituted Adenosines 41
Synthesis of New Nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 40
New insights into the evaluation of the bile salt critical micellar concentration 40
Therapeutic Potential of a Novel Poly(ADP-ribose) Polymerase Inhibitor, Hydamtiq, in Human Pancreatic and Colon Cancers 40
Heterocycles as companions on route to drug discovery 39
Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin 39
Heterocycles as Companions on Route to Drug Discovery 39
Characterization of potent ligands at human recombinant adenosine receptors 39
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure 38
High-throughput chromatographic determination of the bile acid critical micellar concentration 38
Synthesis and biological activity of 3'-deoxy derivative of adenosine (5'-N-methylcarboxamide) (MECA) 38
Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent 37
Fast chromatographic determination of the unconjugated bile salt critical micellar concentration 37
Combined strategies toward the design and synthesis, of novel inhibitors of indoleamine-2,3-dioxygenase (IDO) 37
Totale 5.463
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.497
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020458 0 0 0 0 107 7 107 7 109 70 19 32
2020/20211.330 3 107 31 100 405 69 121 29 169 32 119 145
2021/20221.214 33 212 11 54 37 11 13 405 43 51 138 206
2022/20232.058 165 391 30 121 178 215 3 83 760 7 76 29
2023/2024851 47 104 44 12 7 15 182 29 88 28 132 163
2024/2025586 22 202 73 62 227 0 0 0 0 0 0 0
Totale 7.352